Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v2-FR
Language French French
Date Updated 2022-08-19 2021-10-13
Drug Identification Number 02352230 02352230
Brand name RAN-ENALAPRIL RAN-ENALAPRIL
Common or Proper name RAN ENALAPRIL 2.5mg 100 Tablet / Comprimé RAN ENALAPRIL 2.5mg 100 Tablet / Comprimé
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients ENALAPRIL SODIUM ENALAPRIL SODIUM
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-27 2021-09-01
Estimated end date 2022-08-26 2021-11-19
Actual end date 2022-05-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments